Evidence that Fe-NTA-induced renal prostaglandin F2α is responsible for hyperplastic response in kidney: Implications for the role of cyclooxygenase-dependent arachidonic acid metabolism in renal tumor promotion

Biochemistry and Molecular Biology International

Volumn 42, Issue 6, 1997, Pages 1115-1124

  Iqbal, Mohammad ^a   Giri, Uma ^a   Giri, Dipak K ^a   Athar, Mohammad ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Cyclooxygenase; Iron; Nitriloacetic acid; Oxidative stress; Prostaglandin F2

Indexed keywords

ARACHIDONIC ACID; DNA; INDOMETACIN; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN SYNTHASE; TUMOR PROMOTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARACHIDONIC ACID METABOLISM; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVATION; HISTOPATHOLOGY; HYPERPLASIA; KIDNEY CANCER; KIDNEY DISEASE; MALE; NONHUMAN; RAT;

ANIMALIA;

EID: 0031398380     PISSN: 10399712     EISSN: None     Source Type: Journal    
DOI: 10.1080/15216549700203581     Document Type: Article

References (22)

1. Hamazaki, S., Okada, S., Ebina, Y. and Midorikawa, O. (1985) Toxicol. Appl. Pharmacol., 77, 267-274.
2. Hamazaki, S., Okada, S., Li, J-L., Toyokuni, S. and Midorikawa, O. (1989) Arch. Biochem. Biophys., 272, 10-17.
3. Ebina, Y., Okada, S., Hamazaki, S., Ogino, F., Li, J.-L. and Midorikawa, O. (1986) J. Natl. Cancer Inst., 76, 107-113.
4. Inoue, S. and Kawanishi, S. (1987) Cancer Res., 47, 6522-6527.
5. Toyokuni, S., Mori, T., Hiai, H., Dizdaroglu, M. (1995) Int. J. Cancer., 62, 309-313.
6. Toyokuni, S., Uchida, K., Okamato, K., Nakakuki, Y.H., Hiai, H., and Stadtman, E.R. (1994). Proc. Natl. Acad. Sci. USA., 91, 2616-2620.
7. Iqbal, M., Sharma, S.D., Zadeh, H. R., Hasan, N., Abdullah, M. and Athar, M. (1996) Redox Report, 2, 385-391.
8. Iqbal, M., Giri, U., and Athar, M. (1995) Biochem. Biophys. Res. Commun., 212, 557-563.
9. Cerutt, P. (1985) Science, 227, 375-381.
10. Hemler, M., H and Lands, W. (1979) Arch.Biochem.Biophys. 193, 340-345.
11. Furstenburger, G; Gross, M and Marks, F. (1984) In Icosanoids and cancer (ed. H. Thaler Dao et al.), P-91. Ravenpress, New York.
12. Furstenberger, G and Marks ,F. (1978) Biochem.Biophys.Res.Commun. 84, 1103-1111.
13. Stahl, R.A.K., Attallah , A.A., Bloch, D.L., and Lee, J.B. (1979) Am.J.Physiol. 237, F 344.
14. Athar, M., Raza, H., Bickers, D.R. and Mukhtar, H. (1990). J. Invest. Dermatol., 94, 162-165.
15. Giri, U., Sharma, S.D., Abdulla, M. and Athar, M. (1995). Biochem. Biophys. Res. Commun., 209, 698-705.
16. Giri, U., Iqbal. M. and Athar, M. (1996) Carcinogenesis, 17, 2023-2028.
17. Mukhtar, H., Merk, H.F. and Athar, M. (1989) Skin chemical carcinogenesis. Clinics in Dermatol., 7, 1-10.
18. Athar, M. Mukhtar, H., Bickers, D.R., Khan, I.U., and Kalyanaraman, B. (1989) Carcinogenesis, 10, 1499-1503.
19. Umemura, T., Sai, K., Takagi, A., Hasegawa, R. and Kurokawa, Y. (1995) Carcinogenesis, 16, 593-597.
20. Husain, M., Mustafa, M., Ghani, Q., and Bhatnagar, R. (1985) Arch.Biochem.Biophys. 241, 477-485.
21. Ager, A. and Gordon, J. (1984) J.Exp.Med, 159, 592-603.
22. Morrow , J.D., Hill , K.E., Burk, R,E., Nammour, T.M., Badr, K.F., Roberts, L.J.(1990) Proc.Natl.Acad. Sci.USA 87, 9383-9387.